- Home
- SGC vs PROF Comparison
SGC vs PROF Comparison
Compare SGC & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGC
- PROF
- Stock Information
- Founded
- SGC 1920
- PROF N/A
- Country
- SGC United States
- PROF Canada
- Employees
- SGC N/A
- PROF N/A
- Industry
- SGC Apparel
- PROF Medical/Dental Instruments
- Sector
- SGC Consumer Discretionary
- PROF Health Care
- Exchange
- SGC Nasdaq
- PROF Nasdaq
- Market Cap
- SGC 252.6M
- PROF 238.5M
- IPO Year
- SGC N/A
- PROF N/A
- Fundamental
- Price
- SGC $15.16
- PROF $7.69
- Analyst Decision
- SGC Strong Buy
- PROF Strong Buy
- Analyst Count
- SGC 2
- PROF 2
- Target Price
- SGC $22.00
- PROF $11.40
- AVG Volume (30 Days)
- SGC 77.0K
- PROF 67.4K
- Earning Date
- SGC 11-04-2024
- PROF 10-31-2024
- Dividend Yield
- SGC 3.70%
- PROF N/A
- EPS Growth
- SGC N/A
- PROF N/A
- EPS
- SGC 0.68
- PROF N/A
- Revenue
- SGC $553,945,000.00
- PROF $7,880,000.00
- Revenue This Year
- SGC $4.89
- PROF $56.87
- Revenue Next Year
- SGC $4.84
- PROF $161.94
- P/E Ratio
- SGC $22.34
- PROF N/A
- Revenue Growth
- SGC 1.22
- PROF 16.67
- 52 Week Low
- SGC $7.42
- PROF $7.11
- 52 Week High
- SGC $21.80
- PROF $11.69
- Technical
- Relative Strength Index (RSI)
- SGC 52.33
- PROF 42.53
- Support Level
- SGC $14.79
- PROF $7.55
- Resistance Level
- SGC $15.28
- PROF $7.89
- Average True Range (ATR)
- SGC 0.33
- PROF 0.27
- MACD
- SGC 0.00
- PROF 0.03
- Stochastic Oscillator
- SGC 51.58
- PROF 22.27
About SGC Superior Group of Companies Inc.
Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.